Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp BRISTOL-MYERS SQUIBB-CVR stake
total: 197
Muhlenkamp & Co BMYRT trades
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 3
- Held since:
- 2019 Q4
- Held for:
- 4 quarters
- Latest activity:
- 2021 Q1
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any BRISTOL-MYERS SQUIBB-CVR (BMYRT) shares. To date, the estimated cost basis is nearly $3.01 for "buy" trades and estimated average "sell" price is $0.72. Muhlenkamp & Co first purchased BMYRT in 2019 Q4, initially acquiring 70,665 shares. Since the initial investment in BRISTOL-MYERS SQUIBB-CVR (BMYRT), Muhlenkamp & Co has made 4 more transactions.
When did Ronald Muhlenkamp sell BRISTOL-MYERS SQUIBB-CVR (BMYRT)?
Ronald Muhlenkamp sold off the entire BRISTOL-MYERS SQUIBB-CVR (BMYRT) position in 2021 Q1.
When did Ronald Muhlenkamp buy BRISTOL-MYERS SQUIBB-CVR (BMYRT)?
Ronald Muhlenkamp first invested in BRISTOL-MYERS SQUIBB-CVR (BMYRT) in 2019 Q4 at the reported quarter-end price of $3.01 per share.
What's the cost basis of Muhlenkamp & Co's BMYRT stake?
The estimated cost basis for BRISTOL-MYERS SQUIBB-CVR (BMYRT) stake is around $3.01 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $3.01
- Weighted AVG sell price:
- $0.72
Ronald Muhlenkamp's historical trades in BRISTOL-MYERS SQUIBB-CVR
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q1
|
0.00%
|
0
|
$0.69
|
|
-100% (-69,403)
|
-0.02%
|
|
2020 Q4
|
0.02%
|
$0.69
|
-0.85% (-593)
|
|||
|
2020 Q3
|
0.08%
|
$2.24
|
-0.18% (-125)
|
|||
|
2020 Q2
|
0.13%
|
$3.58
|
-0.77% (-544)
|
|||
|
2019 Q4
|
0.09%
|
$3.01
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.